SCHEMBL6516159

SCHEMBL6516159

COC(=O)Cn1nc(C)cc1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 3/20 0.47
PKM P14618 1/20 0.47
TSHR P16473 2/20 0.46
MAPK1 P28482 1/20 0.46
LMNA P02545 3/20 0.45
POLB P06746 1/20 0.44
GAA P10253 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
RAB9A P51151 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
FPR1 P21462 1/20 0.39
FPR2 P25090 1/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15656246 0.85 ALDH1A1 (0.61) ALDH1A1KDM4ETSHRMAPK1LMNA
Hydrochloric Acid SCHEMBL21847655 0.84 ALDH1A1 (0.60) ALDH1A1KDM4ETSHRMAPK1LMNA
SCHEMBL20037188 0.83 LMNA (0.66) ALDH1A1KDM4EPKMLMNAPOLB
SCHEMBL19207549 0.81 KDM4E (0.50) ALDH1A1KDM4EPKMTSHRLMNA
SCHEMBL11783550 0.81 LMNA (0.68) ALDH1A1KDM4EPKMTSHRMAPK1
SCHEMBL15931406 0.80 LMNA (0.45) ALDH1A1KDM4EPKMTSHRLMNA
SCHEMBL21960838 0.79 ALDH1A1 (0.39) ALDH1A1KDM4EPKMTSHRKMT2A
SCHEMBL29686758 0.79 LMNA (0.47) ALDH1A1KDM4EPKMTSHRLMNA
SCHEMBL21960820 0.77 NPSR1 (0.49) ALDH1A1KDM4EPKMTSHRMAPK1
SCHEMBL2684789 0.75 ALDH1A1 (0.57) ALDH1A1KDM4ETSHRMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
EP-2254889-B1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2012-12-19 EP disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MAP4K2, MAP3K20, MAP4K1 ALDH1A1 4501/4885KDM4E 1872/4885PKM 407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.